0.7% Official Development Assistance Target Debate

Full Debate: Read Full Debate
Department: HM Treasury

0.7% Official Development Assistance Target

Catherine West Excerpts
Tuesday 8th June 2021

(3 years, 5 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Catherine West Portrait Catherine West (Hornsey and Wood Green) (Lab)
- Hansard - -

It is a pleasure to hear so many Members across the House joining together, looking at the progress that has been made on HIV/AIDS over the years and urging the Government to change their mind on this funding question. I know my hon. Friend the Member for Cardiff South and Penarth (Stephen Doughty), who chairs the all-party group on HIV and AIDS, which is cross-party, has also done an enormous amount of work on this.

I want to talk today about the impact on British science, but before I do I want briefly to mention the many wonderful experiences that we as Members, in different parties, had in, for example, Kenya or Nigeria, where so many children die from malaria. We know that, with the Commonwealth Heads of Government meeting this month, we are meant to be showing a very strong sense of leadership and I feel this kind of decision undermines that.

I was very pleased to hear the right hon. Member for Gainsborough (Sir Edward Leigh) talk about the waste of the in-year cut. When we cut budgets in-year, we may as well not spend the money at all; we just throw it away. So some medication that is being provided through programmes will actually be disposed of because of an in-year cut. It is a really bad way to manage programmes.

On British science, I declare an interest because my other half is a scientist and is very involved in malaria research. I understand that Dr Gilbert, who in Oxford invented the vaccine, invented it because she has a background in trying to find a vaccine for malaria. It is a very different kind of parasite from coronavirus—of course, coronavirus is much simpler, so it is much easier to get a vaccine—but the reason she is a vaccinologist and understands vaccines is that she worked in global health, and the UK is known for its excellence in that area.

These ODA cuts will have a massive impact on our regional universities. Of course, what we are trying to address are the regional inequalities within the UK. We know, for example—and the hon. Member for Winchester (Steve Brine) mentioned the trust in Hampshire—that there are 500 health facilities across Africa and Asia that work closely with the Liverpool School of Tropical Medicine. They teach medical science and medical research to Africans and in Asia as well. In particular, the concept is so good—this was one of the special things about many of the DFID programmes: it was a hand up, not a handout. Everybody wants to see these programmes where British scientists work closely with African scientists. They are equal scientists, and they work together and collaborate. It is not just handing out in a kind of philanthropic way to make us feel good; it is working on the global problems that affect each and every one of us. We are so far ahead in our vaccine project because of that background in global health.

This debate is taking place in the context of The Times rich list, where there are 23 more billionaires this year. Our economy has the potential, but we have to make our economy work harder so that we can afford this, because it is inequality that is going to bring down our society, which is going to cause even more problems, and we must tackle that difficult problem. Christine Lagarde has been saying it for years, and the IMF is saying it. Tackle inequality, and the rest will look after itself. We have to find a way for the 23 billionaires to help to pay for the £4 billion that we need to maintain this UK excellence across the world.